Compile Data Set for Download or QSAR
maximum 50k data
Found 29 with Last Name = 'bruzgo' and Initial = 'i'
TargetProthrombin(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233008(H-D-Ser-Ala-Arg-NH-(CH2)8-NH2 (7))
Affinity DataKi:  240nMpH: 8.4Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSerine protease 1(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233006(H-D-Ser-Ala-Arg-NH-(CH2)6-NH2 (5))
Affinity DataKi:  2.50E+3nMpH: 7.5Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSerine protease 1(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233009(H-D-Ser-Ala-Arg-NH-(CH2)9-NH2 (8))
Affinity DataKi:  5.00E+3nMpH: 7.5Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233005(H-D-Ser-Ala-Arg-NH-(CH2)5-NH2 (4))
Affinity DataKi:  6.30E+3nMpH: 8.8Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSerine protease 1(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233008(H-D-Ser-Ala-Arg-NH-(CH2)8-NH2 (7))
Affinity DataKi:  1.00E+4nMpH: 7.5Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSerine protease 1(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233012(H-D-Ser-Ala-Arg-NH-(CH2)4-OH (11))
Affinity DataKi:  1.00E+4nMpH: 7.5Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSerine protease 1(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233011(H-D-Ser-Ala-Arg-NH-(CH2)3-OH (10))
Affinity DataKi:  1.50E+4nMpH: 7.5Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSerine protease 1(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233007(H-D-Ser-Ala-Arg-NH-(CH2)7-NH2 (6))
Affinity DataKi:  3.00E+4nMpH: 7.5Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233005(H-D-Ser-Ala-Arg-NH-(CH2)5-NH2 (4))
Affinity DataKi:  3.70E+4nMpH: 7.4Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233008(H-D-Ser-Ala-Arg-NH-(CH2)8-NH2 (7))
Affinity DataKi:  8.70E+4nMpH: 8.8Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233009(H-D-Ser-Ala-Arg-NH-(CH2)9-NH2 (8))
Affinity DataKi:  9.00E+4nMpH: 7.4Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233006(H-D-Ser-Ala-Arg-NH-(CH2)6-NH2 (5))
Affinity DataKi:  1.81E+5nMpH: 7.4Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233007(H-D-Ser-Ala-Arg-NH-(CH2)7-NH2 (6))
Affinity DataKi:  2.44E+5nMpH: 8.8Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233009(H-D-Ser-Ala-Arg-NH-(CH2)9-NH2 (8))
Affinity DataKi:  2.93E+5nMpH: 8.8Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233007(H-D-Ser-Ala-Arg-NH-(CH2)7-NH2 (6))
Affinity DataKi:  3.64E+5nMpH: 7.4Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233012(H-D-Ser-Ala-Arg-NH-(CH2)4-OH (11))
Affinity DataKi:  5.45E+5nMpH: 7.4Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233010(H-D-Ser-Ala-Arg-NH-(CH2)2-OH (9))
Affinity DataKi:  7.27E+5nMpH: 7.4Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233011(H-D-Ser-Ala-Arg-NH-(CH2)3-OH (10))
Affinity DataKi:  1.09E+6nMpH: 7.4Assay Description:Determination of amidolytic activity was performed as described previously [Okada et al., Chem. Pharm. Bull., 36:1289-1297]. Detailed description of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM45440(4-[5-(4-amidinophenoxy)pentoxy]benzamidine;2-hydro...)
Affinity DataIC50: <1.00E+4nMAssay Description:Quantities of 0.2 mL of examined preparation (as control, 0.15 M NaCl), buffer, and 0.1 mL of enzyme solution were mixed together. The mixture was in...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233163(Carbocyclic minor groove binder, 5)
Affinity DataIC50:  1.00E+4nMAssay Description:Quantities of 0.2 mL of examined preparation (as control, 0.15 M NaCl), buffer, and 0.1 mL of enzyme solution were mixed together. The mixture was in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233164(Carbocyclic minor groove binder, 6)
Affinity DataIC50:  1.00E+4nMAssay Description:Quantities of 0.2 mL of examined preparation (as control, 0.15 M NaCl), buffer, and 0.1 mL of enzyme solution were mixed together. The mixture was in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233164(Carbocyclic minor groove binder, 6)
Affinity DataIC50:  1.40E+4nMAssay Description:Quantities of 0.2 mL of examined preparation (as control, 0.15 M NaCl), buffer, and 0.1 mL of enzyme solution were mixed together. The mixture was in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233162(Carbocyclic minor groove binder, 4)
Affinity DataIC50:  2.00E+4nMAssay Description:Quantities of 0.2 mL of examined preparation (as control, 0.15 M NaCl), buffer, and 0.1 mL of enzyme solution were mixed together. The mixture was in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM45440(4-[5-(4-amidinophenoxy)pentoxy]benzamidine;2-hydro...)
Affinity DataIC50:  2.00E+4nMAssay Description:Quantities of 0.2 mL of examined preparation (as control, 0.15 M NaCl), buffer, and 0.1 mL of enzyme solution were mixed together. The mixture was in...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine protease 1(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233164(Carbocyclic minor groove binder, 6)
Affinity DataIC50:  2.00E+4nMAssay Description:Quantities of 0.2 mL of examined preparation (as control, 0.15 M NaCl), buffer, and 0.1 mL of enzyme solution were mixed together. The mixture was in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM233163(Carbocyclic minor groove binder, 5)
Affinity DataIC50:  2.00E+4nMAssay Description:Quantities of 0.2 mL of examined preparation (as control, 0.15 M NaCl), buffer, and 0.1 mL of enzyme solution were mixed together. The mixture was in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM50055660(1-amino-3-(4-(4-(2-(amino(iminio)methylamino)aceta...)
Affinity DataIC50:  3.00E+4nMAssay Description:Quantities of 0.2 mL of examined preparation (as control, 0.15 M NaCl), buffer, and 0.1 mL of enzyme solution were mixed together. The mixture was in...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM50055660(1-amino-3-(4-(4-(2-(amino(iminio)methylamino)aceta...)
Affinity DataIC50:  4.00E+4nMAssay Description:Quantities of 0.2 mL of examined preparation (as control, 0.15 M NaCl), buffer, and 0.1 mL of enzyme solution were mixed together. The mixture was in...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine protease 1(Homo sapiens (Human))
Medical University of Bialystok

LigandPNGBDBM45440(4-[5-(4-amidinophenoxy)pentoxy]benzamidine;2-hydro...)
Affinity DataIC50:  1.00E+5nMAssay Description:Quantities of 0.2 mL of examined preparation (as control, 0.15 M NaCl), buffer, and 0.1 mL of enzyme solution were mixed together. The mixture was in...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed